Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B-Reference-Cited by-同舟云学术

Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B

Published:2008-12-02 Issue:4 Volume:49 Page:1141-1150
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Brunetto Maurizia Rossana,Moriconi Francesco,Bonino Ferruccio,Lau George K. K.,Farci Patrizia,Yurdaydin Cihan,Piratvisuth Teerha,Luo Kangxian,Wang Yuming,Hadziyannis Stephanos,Wolf Eva,McCloud Philip,Batrla Richard,Marcellin Patrick

Publisher

Wiley

Subject

Hepatology

Reference27 articles.

1. Current issues and future directions in treatment;Hui;Semin Liver Dis,2006

2. Chronic hepatitis B infection and mortality from non-liver causes: results from the Haimen cohort study;Chen;Int J Epidemiol,2005

3. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B;Hsu;Hepatology,2002

4. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B;Niederau;N Engl J Med,1996

5. Hepatitis B e antigen-negative chronic hepatitis B;Hadziyannis;Hepatology,2001

Cited by 422 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CXCR7 genetic variant predicts treatment response of pegylated-interferon α in HBeAg-positive chronic hepatitis B patients;Antiviral Research;2024-11

2. Potential role of microRNAs in personalized medicine against hepatitis: a futuristic approach;Archives of Virology;2024-01-21

3. Predictors of therapeutic response to peginterferon α‑2a and nucleos(t)ide analog combination therapy for HBeAg‑negative chronic hepatitis B: 1‑year follow‑up after treatment;Experimental and Therapeutic Medicine;2023-11-03

4. Establishment of a multi-parameter prediction model for the functional cure of HBeAg-negative chronic hepatitis B patients treated with pegylated interferonα and decision process based on response-guided therapy strategy;BMC Infectious Diseases;2023-07-10

5. The role of different viral biomarkers on the management of chronic hepatitis B;Clinical and Molecular Hepatology;2023-04-01